查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1970840

医药物流市场－全球产业规模、份额、趋势、机会、预测：按类型、按组件、按地区和竞争对手划分，2021-2031年

Pharmaceutical Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Component, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球医药物流市场预计将从 2025 年的 948.8 亿美元成长到 2031 年的 1,435.9 亿美元，复合年增长率为 7.15%。

该市场涵盖医疗产品的采购、仓储和运输的专业管理，确保产品从生产到最终使用的完整性和有效性。推动这一市场成长的关键因素包括：全球对温度生物製药和疫苗的需求不断增长，这些产品需要精准的低温运输管理；以及严格的药品良好分销规范 (GDP) 法规要求提高供应链的安全性和可追溯性。

市场概览
预测期 2027-2031
市场规模：2025年 948.8亿美元
市场规模：2031年 1435.9亿美元
复合年增长率：2026-2031年 7.15%
成长最快的细分市场 低温运输物流
最大的市场 北美洲

例如，医疗保健分销商联盟 (HDA) 的报告显示，到 2024 年，美国药品经销商的销售额将增长 10.4%，达到 8,620 亿美元，这凸显了物流网络面临的日益增长的压力。儘管如此，由于不同国际司法管辖区的监管碎片化，该市场仍面临许多障碍。这种复杂性造成了合规瓶颈，并增加了跨境运输的营运成本，从而阻碍了市场的进一步扩张。

市场驱动因素

对温控生物製药和特种药品的需求激增正在改变市场格局，这要求物流供应商提升处理高以金额为准、易变化合物的能力。与传统的小分子药物不同，单株抗体和基因疗法等先进医疗手段需要在整个价值链中严格控制温度，以防止劣化。随着这一转变促使製造商将产品完整性置于首位，专业低温运输空运货物的处理量正在显着增长。例如，IAG Cargo报告称，其2024年恆温运输产品的处理量年增22%，凸显了业界对精准运输解决方案日益增长的需求。

同时，扩大全球低温运输基础设施和温控物流已成为当务之急，製造商越来越多地将这些复杂的营运外包给专业的第三方物流(3PL) 服务商。为了满足现代医疗产品严格的储存要求，领先的物流整合商正积极拓展其全球业务，建造符合良好分销规范 (GDP) 的设施。例如，UPS 于 2024 年 9 月确认，其医疗保健网路目前已覆盖 1,700 万平方英尺的合规配送空间。基础设施的扩张支撑着蓬勃发展的物流环境，国际航空运输协会 (IATA) 的报告也印证了这一点：2024 年全球航空货运需求增加了 11.3%。这凸显了跨境医药供应链贸易的强劲发展动能。

市场挑战

不同国际司法管辖区监管规定的碎片化，对全球医药物流市场的成长构成重大障碍。物流业者必须应对各国在药品良好分销规范 (GDP)、序列化和进出口通讯协定方面的复杂差异，这导致管理负担沉重，营运效率降低。这种分散化迫使企业维护多套合规体系，并投入大量资源来满足各种文件要求，直接增加跨国贸易成本，并在海关入境口岸造成严重拥挤。

这些监管壁垒造成了实际的营运摩擦，阻碍了全球供应链的顺畅运作。 2025年，医疗保健分销商联盟（HDA）指出，复杂的追溯规则导致批发商发现约2%的序列化药品存在数据差异，而解决这些问题往往需要数週时间。此类与合规性相关的延误会扰乱库存管理，迫使物流网路增加安全库存，从而增加营运资金需求，并限制市场的整体成长潜力。

市场趋势

仓储自动化和机器人流程整合正成为物流供应商应对劳动力短缺和提升医药供应链营运效率的关键策略。引入自主移动机器人 (AMR) 和自动化仓储系统，能够有效管理医疗试剂盒和临床试验材料的复杂拣选需求，减少人为错误，并提高处理能力。 DHL 集团等产业领导企业正积极实践这项技术主导的效率提升趋势。 2025 年 7 月，DHL 集团宣布投资 5.5 亿英镑，用于扩展其自动化基础设施，并部署 1,000 多台新机器人，以支援生命科学领域的蓬勃发展。

同时，随着製药业将低温运输营运与永续性目标相契合，可重复使用的温控包装的应用也日益增多。与一次性被动式系统不同，这些主动式可重复使用包装能够为高价值货物提供更优异的温度稳定性，并透过循环物流网路减少范围3的排放。 Envilotainor 2025年4月发布的报告重点强调了这一转变，该报告显示，2024年药品出货量年增8.9%。这反映了製药业正在向永续的循环包装解决方案转型，以最大限度地减少废弃物和碳排放。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球医药物流市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（低温运输物流、非低温运输物流）
    • 按组件（储存组件、传输组件和监控组件）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美医药物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲医药物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区医药物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东与非洲医学流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美医药物流市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球医药物流市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • DHL Life Sciences
  • UPS Healthcare
  • FedEx
  • Kuehne+Nagel
  • Deutsche Post DHL
  • DB Schenker
  • Ceva Logistics
  • Agility Logistics
  • Marken
  • AmerisourceBergen

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25437

The Global Pharmaceutical Logistics Market is projected to expand from USD 94.88 Billion in 2025 to USD 143.59 Billion by 2031, registering a CAGR of 7.15%. This market involves the specialized management of procurement, warehousing, and transportation for medical products, ensuring their integrity and efficacy from production to end-use. Key drivers fueling this growth include the increasing global demand for temperature-sensitive biologics and vaccines, which necessitates precise cold chain handling, along with strict Good Distribution Practice regulations that require enhanced security and traceability within the supply chain.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 94.88 Billion
Market Size 2031USD 143.59 Billion
CAGR 2026-20317.15%
Fastest Growing SegmentCold Chain Logistics
Largest MarketNorth America

Illustrating the growing pressure on these logistics networks, the Healthcare Distribution Alliance reported that sales through U.S. pharmaceutical distributors rose by 10.4 percent to reach $862 billion in 2024. Despite this growth, the market faces a substantial obstacle in the form of regulatory fragmentation across various international jurisdictions. This complexity leads to compliance bottlenecks and elevates operational costs for cross-border shipments, thereby hindering broader market expansion.

Market Driver

The surge in demand for temperature-sensitive biologics and specialty medicines is transforming the market, necessitating that logistics providers enhance their handling capabilities for high-value, unstable compounds. Unlike conventional small-molecule drugs, advanced therapies such as monoclonal antibodies and gene treatments demand rigorous temperature control throughout the supply chain to prevent spoilage. This shift has led to a notable increase in volume for specialized cold-chain air freight, as manufacturers prioritize product integrity; for example, IAG Cargo reported a 22 percent year-on-year tonnage increase for its Constant Climate product in 2024, highlighting the industry's growing need for precise transport solutions.

simultaneously, the expansion of global cold chain infrastructure and cryogenic logistics has become a priority, with manufacturers increasingly outsourcing these complex operations to specialized Third-Party Logistics (3PL) providers. To meet the strict storage needs of modern medical products, major logistics integrators are aggressively expanding their global presence with Good Distribution Practice (GDP) compliant facilities. UPS, for instance, confirmed in September 2024 that its healthcare network now includes 17 million square feet of compliant distribution space. This infrastructure growth supports a bustling logistics environment, evidenced by the International Air Transport Association's report of an 11.3 percent rise in global air cargo demand in 2024, underscoring the strong cross-border trade momentum within the pharmaceutical supply chain.

Market Challenge

Regulatory fragmentation across diverse international jurisdictions presents a significant barrier to the growth of the Global Pharmaceutical Logistics Market. Logistics providers must navigate a complex array of differing national standards regarding Good Distribution Practice (GDP), serialization, and import-export protocols, which creates compounded administrative burdens that reduce operational efficiency. This fragmentation compels companies to maintain multiple compliance systems and allocate considerable resources to varying documentation requirements, directly raising the cost of cross-border trade and causing severe bottlenecks at customs entry points.

These regulatory obstacles create tangible operational friction that hampers the fluidity of global supply chains. In 2025, the Healthcare Distribution Alliance noted that wholesalers found data discrepancies in approximately 2 percent of serialized pharmaceutical products due to complex traceability rules, with resolutions often taking weeks. Such compliance-related delays disrupt inventory management and force logistics networks to hold larger safety stocks, inflating working capital needs and restricting the market's overall growth potential.

Market Trends

Warehouse automation and the integration of robotic processes are becoming essential strategies for logistics providers seeking to address labor shortages and improve operational accuracy in the pharmaceutical supply chain. By deploying autonomous mobile robots (AMRs) and automated storage systems, companies can better manage the complex picking requirements for medical kits and clinical trial supplies, thereby reducing human error and boosting throughput. This trend toward technology-driven efficiency is demonstrated by major players like DHL Group, which announced a £550 million investment in July 2025 to expand its automated infrastructure and introduce over 1,000 new robots to support the growing life sciences sector.

Concurrently, the adoption of reusable temperature-controlled packaging is increasing as the industry aligns cold chain operations with sustainability targets. Unlike single-use passive systems, these active reusable containers provide superior temperature stability for high-value shipments and reduce Scope 3 emissions through circular logistics networks. This shift is highlighted by Envirotainer's April 2025 report, which recorded an 8.9 percent year-on-year increase in shipments for 2024, reflecting the pharmaceutical sector's move toward sustainable, circular packaging solutions to minimize waste and carbon impact.

Key Market Players

  • DHL Life Sciences
  • UPS Healthcare
  • FedEx
  • Kuehne+Nagel
  • Deutsche Post DHL
  • DB Schenker
  • Ceva Logistics
  • Agility Logistics
  • Marken
  • AmerisourceBergen

Report Scope

In this report, the Global Pharmaceutical Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Logistics Market, By Type

  • Cold Chain Logistics
  • Non-Cold Chain Logistics

Pharmaceutical Logistics Market, By Component

  • Storage
  • Transportation
  • Monitoring components

Pharmaceutical Logistics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Logistics Market.

Available Customizations:

Global Pharmaceutical Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cold Chain Logistics, Non-Cold Chain Logistics)
    • 5.2.2. By Component (Storage, Transportation, Monitoring components)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
    • 6.3.2. Canada Pharmaceutical Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
    • 6.3.3. Mexico Pharmaceutical Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component

7. Europe Pharmaceutical Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
    • 7.3.2. France Pharmaceutical Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
    • 7.3.3. United Kingdom Pharmaceutical Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
    • 7.3.4. Italy Pharmaceutical Logistics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
    • 7.3.5. Spain Pharmaceutical Logistics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component

8. Asia Pacific Pharmaceutical Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
    • 8.3.2. India Pharmaceutical Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
    • 8.3.3. Japan Pharmaceutical Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
    • 8.3.4. South Korea Pharmaceutical Logistics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
    • 8.3.5. Australia Pharmaceutical Logistics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component

9. Middle East & Africa Pharmaceutical Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
    • 9.3.2. UAE Pharmaceutical Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
    • 9.3.3. South Africa Pharmaceutical Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component

10. South America Pharmaceutical Logistics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Logistics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
    • 10.3.2. Colombia Pharmaceutical Logistics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
    • 10.3.3. Argentina Pharmaceutical Logistics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Component

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Logistics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. DHL Life Sciences
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. UPS Healthcare
  • 15.3. FedEx
  • 15.4. Kuehne+Nagel
  • 15.5. Deutsche Post DHL
  • 15.6. DB Schenker
  • 15.7. Ceva Logistics
  • 15.8. Agility Logistics
  • 15.9. Marken
  • 15.10. AmerisourceBergen

16. Strategic Recommendations

17. About Us & Disclaimer